ACT Alzchem Group AG

164.74USD150.20 EUR · XETRA+1.08%Mkt Cap: 1.77B USDP/E: 23.85

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through t…

Institutional holders10 on file

Key Statistics

Company
Market Cap1.77B USD
Enterprise Value1.80B USD
Revenue (TTM)651.28M USD
Gross Profit427.47M USD
Net Income (TTM)69.60M USD
Revenue/Share64.39 USD
Last Price164.74 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.6K
CountryDE
SectorBasic Materials
IndustrySpecialty Chemicals
ISINDE000A2YNT30
Valuation
P/E (Trailing)23.85
P/E (Forward)19.16
PEG—
EV/EBITDA13.92
EV/Revenue2.77
P/S2.72
P/B5.99
EPS (TTM)7.35 USD
EPS (Forward)9.15 USD
52W Range
135.1331% of range230.99
52W High230.99 USD
52W Low135.13 USD
Profitability
Gross Margin69.34%
Oper. Margin14.88%
EBITDA Margin19.89%
Profit Margin11.29%
ROE24.76%
ROA10.27%
ROIC29.74%
ROCE18.64%
Growth
Revenue Growth9.00%
Earnings Growth5.80%
Cash Flow & Leverage
Operating CF150.28M USD
CapEx (TTM)—
FCF Margin-8.55%
FCF Yield-3.14%
Net Debt26.90M USD
Net Debt/EBITDA0.21
Net Debt/FCF—
Balance Sheet
Debt/Equity0.17
Current Ratio2.70
Quick Ratio1.74
Book Value/Sh29.24 USD
Cash/Share7.12 USD
Dividends
Fwd Div Rate2.30 USD
Trail. Div Rate2.30 USD
Div. Yield1.31%
5Y Avg Yield3.34%
Payout Ratio31.34%
Ex-Div DateMay 6, 2026
Pay Date—
Splits
Last Split1:10
Split DateJul 1, 2019
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)225.74 USD
Upside (mean)+37.0%
Target Range194.13 USD – 280.78 USD
194.13+37.0% to mean280.78
# Analysts8
Ownership
Shares Out.10.12M
Float5.40M
Insiders31.94%
Institutions49.46%
Technical
SMA 50180.27 (-8.6%)
SMA 200181.31 (-9.1%)
Beta0.39
S&P 52W Chg12.00%
Avg Vol (30d)19.21K
Avg Vol (10d)16.39K
Technical Indicators
RSI (14)49.7
MACD-3.6191
MACD Signal-4.3632
MACD Hist.+0.7441
BB Upper183.53 USD
BB Middle163.62 USD
BB Lower143.71 USD
BB Width24.33%
ATR (14)8.296 USD
Vol Ratio (20d)0.87x

About Alzchem Group (ETR: ACT)

›

Alzchem Group (ETR: ACT) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,565 employees.

The shares were at 150.20 EUR on 18 November 2026, up 13.8% over 52 weeks. Its 52-week range is 123.20 EUR to 210.60 EUR: the price is 28.7% below the high and 21.9% above the low.

At a market capitalisation of 1.62B EUR, it trades at 23.9 times trailing earnings and 19.2 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 30% for ACT. It pays a dividend yielding 1.31% (it pays out 31% of its earnings), against a median of 1.76% among the dividend payers in that peer group.

Alzchem Group reports return on equity of 24.8%, an operating margin of 14.9% and revenue up 9.0% year over year.

Its debt exceeds its cash by 24.53M EUR, a debt-to-equity ratio of 0.17. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 8 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 205.81 EUR is 37.0% above the current price.